The stock of Eyenovia Inc (EYEN) has gone up by 2.85% for the week, with a -55.32% drop in the past month and a -64.60% drop in the past quarter. The volatility ratio for the week is 8.85%, and the volatility levels for the past 30 days are 11.41% for EYEN. The simple moving average for the past 20 days is -33.11% for EYEN’s stock, with a -67.01% simple moving average for the past 200 days.
Is It Worth Investing in Eyenovia Inc (NASDAQ: EYEN) Right Now?
Moreover, the 36-month beta value for EYEN is 1.79. Analysts have varying opinions on the stock, with 1 analysts rating it as a “buy,” 1 as “overweight,” 0 as “hold,” and 0 as “sell.”
The public float for EYEN is 41.76M and currently, short sellers hold a 12.50% of that float. On April 19, 2024, EYEN’s average trading volume was 1.17M shares.
EYEN) stock’s latest price update
The stock of Eyenovia Inc (NASDAQ: EYEN) has increased by 2.67 when compared to last closing price of 0.53.Despite this, the company has seen a gain of 2.85% in its stock price over the last five trading days. Zacks Investment Research reported 2024-04-09 that Eyenovia (EYEN) plunges 18% after sharing plans to consider strategic alternatives involving the sale of the company or assets, amid a severe cash crunch and poor performance of marketed drugs.
Analysts’ Opinion of EYEN
Many brokerage firms have already submitted their reports for EYEN stocks, with Northland Capital repeating the rating for EYEN by listing it as a “Outperform.” The predicted price for EYEN in the upcoming period, according to Northland Capital is $10 based on the research report published on March 01, 2021 of the previous year 2021.
EYEN Trading at -60.64% from the 50-Day Moving Average
After a stumble in the market that brought EYEN to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -90.68% of loss for the given period.
Volatility was left at 11.41%, however, over the last 30 days, the volatility rate increased by 8.85%, as shares sank -53.80% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -69.11% lower at present.
During the last 5 trading sessions, EYEN rose by +2.87%, which changed the moving average for the period of 200-days by -78.10% in comparison to the 20-day moving average, which settled at $0.7832. In addition, Eyenovia Inc saw -73.79% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at EYEN starting from Grant Stuart M., who purchase 100,000 shares at the price of $0.98 back on Mar 28 ’24. After this action, Grant Stuart M. now owns 5,430,715 shares of Eyenovia Inc, valued at $98,000 using the latest closing price.
Grant Stuart M., the 10% Owner of Eyenovia Inc, purchase 50,000 shares at $1.23 during a trade that took place back on Mar 19 ’24, which means that Grant Stuart M. is holding 5,330,715 shares at $61,500 based on the most recent closing price.
Stock Fundamentals for EYEN
Current profitability levels for the company are sitting at:
- -6708.86 for the present operating margin
- -196.93 for the gross margin
The net margin for Eyenovia Inc stands at -7392.56. The total capital return value is set at -1.32. Equity return is now at value -207.83, with -91.15 for asset returns.
Based on Eyenovia Inc (EYEN), the company’s capital structure generated 0.62 points at debt to capital in total, while cash flow to debt ratio is standing at -1.61. The debt to equity ratio resting at 1.65. The interest coverage ratio of the stock is -25.07.
Currently, EBITDA for the company is -24.62 million with net debt to EBITDA at -0.05. When we switch over and look at the enterprise to sales, we see a ratio of 7785.57. The receivables turnover for the company is 0.01for trailing twelve months and the total asset turnover is 0.0. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.73.
Conclusion
To wrap up, the performance of Eyenovia Inc (EYEN) has been bad in recent times. The stock has received a bullish of “buy” and “hold” ratings from analysts. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
